A few other research studies confirmed that the therapeutic effect of sildenafil on PAH is associated with the suppression of TRPC1/6 by PPARγ activation (Gong et al., 2011; Wang et al., 2013a; Zhang D. et al., 2014; Liu et al., 2018). This evidence concerns the gene PPARG and pulmonary arterial hypertension.